Publicacións en colaboración con investigadores/as de Kliniken Essen-Mitte (9)

2023

  1. Development of the NOGGO GIS v1 Assay, a Comprehensive Hybrid-Capture-Based NGS Assay for Therapeutic Stratification of Homologous Repair Deficiency Driven Tumors and Clinical Validation

    Cancers, Vol. 15, Núm. 13

  2. GIInger predicts homologous recombination deficiency and patient response to PARPi treatment from shallow genomic profiles

    Cell Reports Medicine, Vol. 4, Núm. 12

2019

  1. Is there a role for intraperitoneal chemotherapy, including HIPEC, in the management of ovarian cancer?

    Journal of Clinical Oncology, Vol. 37, Núm. 27, pp. 2420-2423

  2. Olaparib plus bevacizumab as first-line maintenance in ovarian cancer

    New England Journal of Medicine, Vol. 381, Núm. 25, pp. 2416-2428

2017

  1. European society of Gynaecological Oncology (ESGO) guidelines for ovarian cancer surgery

    International Journal of Gynecological Cancer, Vol. 27, Núm. 7, pp. 1534-1542

  2. Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer

    Obstetrical and Gynecological Survey

  3. Value of neoadjuvant chemotherapy for newly diagnosed advanced ovarian cancer: A European perspective

    Journal of Clinical Oncology

2016

  1. European society of gynaecologic oncology quality indicators for advanced ovarian cancer surgery

    International Journal of Gynecological Cancer, Vol. 26, Núm. 7, pp. 1354-1363

  2. Niraparib maintenance therapy in platinum-sensitive, recurrent ovarian cancer

    New England Journal of Medicine, Vol. 375, Núm. 22, pp. 2154-2164